Skip to main content
Journal cover image

Electroconvulsive therapy for catatonia in anti-NMDA receptor encephalitis: A case series.

Publication ,  Journal Article
Wadi, L; Mandge, V
Published in: J Neuroimmunol
January 15, 2024

BACKGROUND: Anti-NMDAR encephalitis is the most common cause of immune-mediated catatonia. CASE SERIES: Three females presented with neuropsychiatric symptoms and were empirically treated with first-line immunotherapy and ovarian teratoma resection for suspected autoimmune encephalitis, preceding diagnostic confirmation via NMDAR antibody positivity. They required escalating large doses of benzodiazepines for refractory malignant catatonia resulting in ICU level care. ECT treatments were initiated, and patients were gradually noted to have clinical improvement as was measured by the Bush-Francis Catatonia Rating Scale. CONCLUSIONS: Clinicians should recognize catatonia among patients with suspected anti-NMDAR encephalitis and consider the early implementation of ECT into treatment algorithms.

Duke Scholars

Published In

J Neuroimmunol

DOI

EISSN

1872-8421

Publication Date

January 15, 2024

Volume

386

Start / End Page

578271

Location

Netherlands

Related Subject Headings

  • Receptors, N-Methyl-D-Aspartate
  • Ovarian Neoplasms
  • Neurology & Neurosurgery
  • Humans
  • Female
  • Electroconvulsive Therapy
  • Catatonia
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis
  • 3209 Neurosciences
  • 3204 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wadi, L., & Mandge, V. (2024). Electroconvulsive therapy for catatonia in anti-NMDA receptor encephalitis: A case series. J Neuroimmunol, 386, 578271. https://doi.org/10.1016/j.jneuroim.2023.578271
Wadi, Lara, and Vishal Mandge. “Electroconvulsive therapy for catatonia in anti-NMDA receptor encephalitis: A case series.J Neuroimmunol 386 (January 15, 2024): 578271. https://doi.org/10.1016/j.jneuroim.2023.578271.
Wadi, Lara, and Vishal Mandge. “Electroconvulsive therapy for catatonia in anti-NMDA receptor encephalitis: A case series.J Neuroimmunol, vol. 386, Jan. 2024, p. 578271. Pubmed, doi:10.1016/j.jneuroim.2023.578271.
Journal cover image

Published In

J Neuroimmunol

DOI

EISSN

1872-8421

Publication Date

January 15, 2024

Volume

386

Start / End Page

578271

Location

Netherlands

Related Subject Headings

  • Receptors, N-Methyl-D-Aspartate
  • Ovarian Neoplasms
  • Neurology & Neurosurgery
  • Humans
  • Female
  • Electroconvulsive Therapy
  • Catatonia
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis
  • 3209 Neurosciences
  • 3204 Immunology